vs

Side-by-side financial comparison of CODEXIS, INC. (CDXS) and LCNB CORP (LCNB). Click either name above to swap in a different company.

CODEXIS, INC. is the larger business by last-quarter revenue ($38.9M vs $23.9M, roughly 1.6× LCNB CORP). CODEXIS, INC. runs the higher net margin — 24.7% vs 23.7%, a 1.0% gap on every dollar of revenue. On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs 5.1%). LCNB CORP produced more free cash flow last quarter ($33.4M vs $19.6M). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs 15.7%).

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

LCNB Corp is a United States-based financial holding company that operates through its national bank subsidiary, providing a full suite of retail and commercial banking products and services including deposit accounts, various loan products, wealth management, and insurance solutions primarily to individual consumers, small and medium-sized enterprises and local community organizations across regional markets in Ohio.

CDXS vs LCNB — Head-to-Head

Bigger by revenue
CDXS
CDXS
1.6× larger
CDXS
$38.9M
$23.9M
LCNB
Growing faster (revenue YoY)
CDXS
CDXS
+76.2% gap
CDXS
81.3%
5.1%
LCNB
Higher net margin
CDXS
CDXS
1.0% more per $
CDXS
24.7%
23.7%
LCNB
More free cash flow
LCNB
LCNB
$13.9M more FCF
LCNB
$33.4M
$19.6M
CDXS
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
15.7%
LCNB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CDXS
CDXS
LCNB
LCNB
Revenue
$38.9M
$23.9M
Net Profit
$9.6M
$5.7M
Gross Margin
94.8%
Operating Margin
27.1%
29.2%
Net Margin
24.7%
23.7%
Revenue YoY
81.3%
5.1%
Net Profit YoY
192.5%
-7.6%
EPS (diluted)
$0.13
$0.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDXS
CDXS
LCNB
LCNB
Q4 25
$38.9M
$23.9M
Q3 25
$8.6M
$23.8M
Q2 25
$15.3M
$22.8M
Q1 25
$7.5M
$21.5M
Q4 24
$21.5M
$22.7M
Q3 24
$12.8M
$21.4M
Q2 24
$8.0M
$19.3M
Q1 24
$17.1M
$17.8M
Net Profit
CDXS
CDXS
LCNB
LCNB
Q4 25
$9.6M
$5.7M
Q3 25
$-19.6M
$6.9M
Q2 25
$-13.3M
$5.9M
Q1 25
$-20.7M
$4.6M
Q4 24
$-10.4M
$6.1M
Q3 24
$-20.6M
$4.5M
Q2 24
$-22.8M
$925.0K
Q1 24
$-11.5M
$1.9M
Gross Margin
CDXS
CDXS
LCNB
LCNB
Q4 25
94.8%
Q3 25
71.3%
Q2 25
86.3%
Q1 25
63.8%
Q4 24
83.0%
Q3 24
66.4%
Q2 24
56.6%
Q1 24
71.6%
Operating Margin
CDXS
CDXS
LCNB
LCNB
Q4 25
27.1%
29.2%
Q3 25
-220.3%
35.6%
Q2 25
-83.9%
31.6%
Q1 25
-271.6%
25.6%
Q4 24
-34.2%
32.9%
Q3 24
-129.0%
24.9%
Q2 24
-284.9%
4.9%
Q1 24
-69.6%
12.5%
Net Margin
CDXS
CDXS
LCNB
LCNB
Q4 25
24.7%
23.7%
Q3 25
-228.1%
29.1%
Q2 25
-86.6%
26.0%
Q1 25
-274.3%
21.4%
Q4 24
-48.4%
27.0%
Q3 24
-160.8%
21.2%
Q2 24
-285.2%
4.8%
Q1 24
-67.4%
10.7%
EPS (diluted)
CDXS
CDXS
LCNB
LCNB
Q4 25
$0.13
$0.40
Q3 25
$-0.22
$0.49
Q2 25
$-0.16
$0.41
Q1 25
$-0.25
$0.33
Q4 24
$-0.12
$0.44
Q3 24
$-0.29
$0.31
Q2 24
$-0.32
$0.07
Q1 24
$-0.16
$0.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDXS
CDXS
LCNB
LCNB
Cash + ST InvestmentsLiquidity on hand
$78.2M
$21.6M
Total DebtLower is stronger
$40.1M
$104.4M
Stockholders' EquityBook value
$50.5M
$273.9M
Total Assets
$147.8M
$2.2B
Debt / EquityLower = less leverage
0.79×
0.38×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDXS
CDXS
LCNB
LCNB
Q4 25
$78.2M
$21.6M
Q3 25
$58.7M
$35.9M
Q2 25
$66.3M
$49.8M
Q1 25
$59.8M
$37.7M
Q4 24
$73.5M
$35.7M
Q3 24
$90.3M
$39.4M
Q2 24
$73.2M
$34.9M
Q1 24
$85.5M
$33.0M
Total Debt
CDXS
CDXS
LCNB
LCNB
Q4 25
$40.1M
$104.4M
Q3 25
$39.7M
$104.7M
Q2 25
$39.4M
$105.0M
Q1 25
$29.2M
$104.6M
Q4 24
$28.9M
$155.2M
Q3 24
$28.6M
$155.7M
Q2 24
$28.4M
$162.2M
Q1 24
$28.1M
$162.6M
Stockholders' Equity
CDXS
CDXS
LCNB
LCNB
Q4 25
$50.5M
$273.9M
Q3 25
$38.5M
$269.9M
Q2 25
$55.6M
$263.5M
Q1 25
$49.6M
$258.7M
Q4 24
$66.9M
$253.0M
Q3 24
$73.4M
$253.2M
Q2 24
$61.4M
$245.2M
Q1 24
$79.3M
$233.7M
Total Assets
CDXS
CDXS
LCNB
LCNB
Q4 25
$147.8M
$2.2B
Q3 25
$124.0M
$2.2B
Q2 25
$138.2M
$2.3B
Q1 25
$128.9M
$2.3B
Q4 24
$149.0M
$2.3B
Q3 24
$148.2M
$2.3B
Q2 24
$132.0M
$2.4B
Q1 24
$149.6M
$2.3B
Debt / Equity
CDXS
CDXS
LCNB
LCNB
Q4 25
0.79×
0.38×
Q3 25
1.03×
0.39×
Q2 25
0.71×
0.40×
Q1 25
0.59×
0.40×
Q4 24
0.43×
0.61×
Q3 24
0.39×
0.61×
Q2 24
0.46×
0.66×
Q1 24
0.35×
0.70×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDXS
CDXS
LCNB
LCNB
Operating Cash FlowLast quarter
$20.1M
$34.4M
Free Cash FlowOCF − Capex
$19.6M
$33.4M
FCF MarginFCF / Revenue
50.3%
140.2%
Capex IntensityCapex / Revenue
1.3%
4.0%
Cash ConversionOCF / Net Profit
2.09×
6.08×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M
$54.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDXS
CDXS
LCNB
LCNB
Q4 25
$20.1M
$34.4M
Q3 25
$-7.7M
$14.0M
Q2 25
$-18.0M
$5.5M
Q1 25
$-13.8M
$2.2M
Q4 24
$-16.5M
$93.2M
Q3 24
$-13.0M
$11.9M
Q2 24
$-12.2M
$54.9M
Q1 24
$-7.8M
$-11.9M
Free Cash Flow
CDXS
CDXS
LCNB
LCNB
Q4 25
$19.6M
$33.4M
Q3 25
$-7.9M
$13.7M
Q2 25
$-20.5M
$5.2M
Q1 25
$-15.1M
$2.1M
Q4 24
$-18.2M
$89.4M
Q3 24
$-14.0M
$10.5M
Q2 24
$-12.6M
$53.8M
Q1 24
$-8.9M
$-12.8M
FCF Margin
CDXS
CDXS
LCNB
LCNB
Q4 25
50.3%
140.2%
Q3 25
-91.7%
57.4%
Q2 25
-133.6%
23.0%
Q1 25
-199.6%
10.0%
Q4 24
-85.0%
394.0%
Q3 24
-109.0%
49.0%
Q2 24
-157.5%
278.6%
Q1 24
-52.2%
-71.8%
Capex Intensity
CDXS
CDXS
LCNB
LCNB
Q4 25
1.3%
4.0%
Q3 25
2.1%
1.3%
Q2 25
16.4%
1.0%
Q1 25
16.7%
0.3%
Q4 24
8.3%
16.7%
Q3 24
7.8%
6.7%
Q2 24
5.0%
5.9%
Q1 24
6.6%
4.8%
Cash Conversion
CDXS
CDXS
LCNB
LCNB
Q4 25
2.09×
6.08×
Q3 25
2.02×
Q2 25
0.92×
Q1 25
0.48×
Q4 24
15.23×
Q3 24
2.63×
Q2 24
59.35×
Q1 24
-6.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons